The infectious complications of anabolic-androgenic steroid injection

International Journal of Sports Medicine

Volumn 20, Issue 8, 1999, Pages 563-566

  Rich, Josiah D ^a,b   Dickinson, B P ^a   Feller, A ^a   Pugatch, D ^a   Mylonakis, E ^a  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

Author keywords

AIDS; Hepatitis B; Hepatitis C; HIV; Injection(s); Needle sharing

Indexed keywords

ANABOLIC AGENT; ANDROGEN; CLENBUTEROL; CYANOCOBALAMIN; NANDROLONE; STANOZOLOL; TESTOSTERONE; TESTOSTERONE CIPIONATE;

ADOLESCENT; ADULT; ARTICLE; DRUG ABUSE; ENDOPHTHALMITIS; HEALTH EDUCATION; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION COMPLICATION; INFECTION CONTROL; INTRAMUSCULAR DRUG ADMINISTRATION; MEDICAL INFORMATION; MYCOSIS; SKIN ABSCESS;

ADULT; ANABOLIC AGENTS; DOPING IN SPORTS; EUROPE; FEMALE; HUMANS; INFECTION; INJECTIONS, INTRAMUSCULAR; MALE; NEEDLE SHARING; RISK FACTORS; UNITED STATES;

EID: 0032736435     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-8841     Document Type: Article

References (38)

1. Bagatell CJ, Bremner WJ. Androgens in men - uses and abuses. N Engl J Med 1996; 334: 707-714
2. Bergman RT. Contaminated Drug Supply. The Physic Sports Med 1993; 21: 8
3. Buckley WE, Yesalis CE, Friedl KE, Anderson WA, Streit AL, Wright JE. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 1988; 280: 3441-3445
4. Calabrese LH, Kleiner SM, Barna BP, Skibinski CI, Kirkendall DT, Lahita RG, Lombardo JA. The effects of anabolic steroids and strength training on the human immune response. Med Sci Sports Exer 1989; 21: 386-392
5. Dickinson BP, Rich JD. Infections secondary to anabolic steroid misuse and their prevention. J Perform Enhanc Drugs 1996; 1: 146-150
6. Dickinson BP, Mylonakis E, Strong LL, Rich JD. Potential infections related to anabolic steroid injection in young adolescents. Pediatrics 1999; 103: 694
7. Dipasquale MG. Anabolic steroids. In: Tarter R, Ammerman R, Ott P (eds). Handbook of Substance Abuse, Neurobehavioral Pharmacology. New York, NY: Plenum Press, 1998: 547-565
8. Durant RH, Ashworth CS, Newman C, Rickert VI. Stability of the relationships between anabolic steroid use and multiple substance use among adolescents. J Adol Health 1994; 15: 111-116
9. DuRant RH, Escobedo LG, Heath GW. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics 1995; 96: 23-28
10. DuRant RH, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med 1993; 328: 922-926
11. Ferenchick GS. Validity of self-report in identifying anabolic steroid use among weightlifters. J Gen Intern Med 1996; 11: 554-556
12. Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: A national survey on the regulation of syringes and needles. JAMA 1997; 277: 53-62
13. Henrion R, Mandelbrot I., Delfieu D. Contamination par le VIH a la suite d'injections d'anabolisants. La Presse Medicale 1992; 21: 218
14. Hoberman JM, Yesalis CE. The history of synthetic testosterone. Sci Am 1995; 272: 76-81
15. Hughes TK, Fulep E, Jeulich T, Smith EM, Stanton GJ. Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol 1995; 17: 857-863
16. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131: 32-47
17. Johnson MD, Jay MS, Shoup B. Anabolic steroid use by male adolescents. Pediatrics 1989; 83: 921-924
18. Kann L, Warren CW, Harris WA. Collins JL, Williams BI, Ross JG, Kolbe LJ. Youth risk behaviour surveillance - United States 1995. MMWR Morb Wkly Rep 1996; 45: 1-84
19. Kashkin KB, Kleber HD. Hooked on hormones? An anabolic addiction hypothesis. JAMA 1989; 262: 3166-3170
20. Krauss MD, Van Meter CD, Robertson DW. Be alert for "spot shot" complications. Your Patient and Fitness 1995; 9: 12-14
21. Maropis C, Yesalis CE. Intramuscular abscess: another anabolic steroid danger. The Physic and Sports Med 1994; 22: 105-110
22. Middleman AB, Durant RH. Anabolic steroid use and associated health risk behaviors. Sports Med 1996; 21: 251-255
23. Morbidity and Mortality Weekly Report Recommendations and Reports. MMWR Morb Wkly Rep, 1991; 40: 1-25
24. Nemechek PM. Anabolic steroid users - another potential risk group for HIV infection. N Engl J Med 1991; 325: 357
25. Philips WN. Anabolic Reference guide (Sixth Issue). Golden CO: Mile High Publishing, 1991
26. Plaus WJ, Hermann G. The surgical management of superficial infections caused by atypical mycobacteria. Surgery 1991; 110: 99-105
27. Rastad J, Joborn H, Ljunghall S, Akerstrom G. Gluteal infektion hos styrkelyftare efter injektion av anabola steroider. Läkartidningen 1985; 82: 3407
28. Rich JD, Dickinson BP, Carney JM, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998; 12: 2345-2350
29. Rich JD, Dickinson BP, Liu KL, et al. Strict syringe laws in Rhode Island are associated with high rates of re-using syringes and HIV risks among IDUs. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: S140-141
30. Rich JD, Dickinson BP, Merriman N, Flanigan TP. Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter. Am J Gastroenterol 1998; 93: 1598
31. Rich JD, Dickinson BP, Flanigan TP, Valone SE. Abscess related to anabolic-androgenic steroid injection: case report and review of the literature. Med Sci Sport Exerc 1999; 31: 207-209
32. Scott MJ, Scott MJ Jr. HIV infection associated with injections of anabolic steroids. JAMA 1989; 262: 207-208
33. Slarek HM, Mantovani RP, Erens E, Heisler D, Niederman MS, Fein AM. AIDS in a bodybuilder using anabolic steroids. N Engl J Med 1984; 311: 1701
34. Widder RA, Bartz-Schmidt KU, Geyer H, Brunner R, Kirchoff B, Donike M, Heinman K. Candida albicans endophthalmitis after anabolic steroid abuse. Lancet 1995; 345: 330-331
35. Yesalis C. Incidence of anabolic steroid use: a discussion of methodological issues. In: Yesalis C (ed). Anabolic Steroids in Sport and Exercise. Champaign, Ill: Human Kinetics Publishers, 1993: 49-69
36. Yesalis CE, Kennedy NK, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA 1993; 270: 1217-1221
37. Yesalis CE, Streit AL, Vicary JR. Anabolic Steroid use: indications of habituation among adolescents. J Drug Educ 1989; 19: 103-116
38. Zmuda JM, Fahrenbach MC, Younkin BT. The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. Metabolism 1993; 42: 446-450